Get started
Author

Ron E. Westlund

Abbreviating the Duke Social Support Index for Use in Chronically Ill Elderly Individuals
1993 · Harold G. Koenig, Ron E. Westlund, et al. · Psychosomatics · 547
Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy
2008 · Stephen Johnston, Maureen Trudeau, et al. · Journal of Clinical Oncology · 195
Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2006 · Wenle Xia, John Bisi, et al. · Cancer Research · 150
Lapatinib Antitumor Activity Is Not Dependent upon Phosphatase and Tensin Homologue Deleted on Chromosome 10 in ErbB2-Overexpressing Breast Cancers
2007 · Wenle Xia, Intisar Husain, et al. · Cancer Research · 146
A Brief Depression Scale for Use in the Medically Ill
1992 · HArold G. Koenig, Harvey J. Cohen, et al. · The International Journal of Psychiatry in Medicine · 99
Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression‐free survival in patients with HER2‐positive metastatic breast cancer receiving lapatinib monotherapy
2011 · Allan Lipton, Kim Leitzel, et al. · Cancer · 23
Data from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Figure S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
PDF
Supplementary Table S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Figure S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Table S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
PDF
Supplementary Figure S3 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Figure S4 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Figure S4 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
PDF
Supplementary Figure S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Table S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Table S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
PDF
Data from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
Supplementary Figure S3 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
PDF
Supplementary Figure S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023 · Wenle Xia, John Bisi, et al.
PDF
Abbreviated Duke Social Support Index
1993 · Harold G. Koenig, Ron E. Westlund, et al. · PsycTESTS Dataset
Works count: 21
Citation count: 1,160
H-index: 6
I10-index: 6
Year
Topic
Type